سعيد بفرصة الحضور والمشاركة بعرض بحث شفهي في مؤتمر الأشعة التداخلية عن (Transarterial Chemoembolization). شكراً لفريق البحث ولجميع من عمل لانجاح هذا المؤتمر. #SIRS_2025

“It’s no longer systemic therapy versus TACE.” Interventional radiologist Dr. Julius Chapiro and oncologist Dr. Richard Finn explain how systemic therapies can now be combined with transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC). Watch

Original . Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma. Yang et al. #LiverX.

This was a relatively hypovascular hepatocellular carcinoma on MRI & angiography, but intra-procedural cone beam CT was helpful in localizing the area for treatment. There was an excellent response to chemoembolization on follow up imaging. #IRad

Our work on next-gen chemoembolization is the cover article in Advanced Materials! With this approach, we show instant non-radioactive segmental embolization, uniform delivery of large therapeutics ie, Nivolumab, and targeted segmental/tumor ablation using the portal veins.

Transarterial chemoembolization (TACE) has been a cornerstone of treatment for intermediate-stage hepatocellular carcinoma (HCC) for over 30 years, undergoing several key evolutions during that time. Interventional radiologist Dr. Julius Chapiro discusses these developments,

How does a medical oncologist weigh different options for their patient’s liver-directed therapy, especially when randomized clinical trials are not available? Dr. Richard Finn discusses his viewpoints on safety and survival outcomes with transarterial chemoembolization (TACE),

📢Hepatopancreaticobiliary-NET abstracts in #ESMO24 @myESMO . ➡️HCC.✅LBA3 - Transarterial Chemoembolization (TACE) With or Without Lenvatinib (len) + Pembrolizumab (pembro) for Intermediate-Stage Hepatocellular Carcinoma (HCC): Phase 3 LEAP-012 Study. ✅LBA38 - Iparomlimab and

Use of high-dose-rate brachytherapy in patients with unresectable hepatocellular carcinoma may improve overall survival and progression-free survival compared to transarterial chemoembolization. A #Tweetorial of a study published in Radiology.

A direct hit against cancer: How transarterial chemoembolization (TACE) delivers targeted therapy to hepatocellular carcinoma with precision

LEAP-012: A Phase 3 Study of Lenvatinib Plus Pembrolizumab Plus Transarterial Chemoembolization for Intermediate-Stage HCC.@ILCA.👉meaningful improvement in ORR & PFS.👉OS immature.🧐TACE + ICI based💊is a great option for downsizing & disease control in HCC.@myESMO @EASLedu

#Healthcare | 🎉 Breakthrough in liver cancer treatment! Chief Physician Zhang Bo's team developed ICN-LPE, a stable lipiodol Pickering emulsion stabilized by iron-doped carbon nanozymes. 💉 . This dual-therapeutic chemoembolization combines chemo & chemodynamic therapies,

From the Mayo Clinic AZ NIH funded IR lab, the future of chemoembolization! @rahmioklu

Effect of neoadjuvant transarterial chemoembolization followed by resection versus upfront liver resection on the survival of single large hepatocellular carcinoma patients: A systematic review and meta-analysis.🌷28(3) Indah Jamtani.#Hepatectomy #SLHCC

Dr. Pushan Sharma (MD, FNB Neurovascular Intervention) from the Department of Radiodiagnosis and Interventional Radiology at SRN Hospital and MLN Medical College, Prayagraj, successfully performed a three-hour procedure known as Transarterial Chemoembolization (TACE) on a liver

#LiverCancer.▶️Efficacy and safety of lenvatinib-transcatheter arterial chemoembolization sequential therapy for hepatocellular carcinoma within the up-to-seven criteria.👉 #LiverX @WileyHealth

❓ Are there any control examinations before the chemoembolization? .Prof. Thomas Vogl tells us about the control examinations before the start of chemoembolization. 📹Interview with doctor: .#BookingHealth #askthedoctor #chemoembolization

Congratulations to @uab_ir resident Russ Guidry & #IRad attending Aliaksei Salei who got their abstract on same-day discharge and re-admission rates after chemoembolization accepted to #SIR24SLC!

Review Article.Local Treatment of #Desmoid #Tumors:.#irad #radtwitter #radiology #MedTwitter #chemoembolization

#ThrowbackThursday! Back to 2022 ↩️.Initiative on Superselective Conventional Transarterial #Chemoembolization Results (INSPIRE).#OpenAccess 🔓